If the treatment is a drug that has not been approved by the Food and Drug Administration or has not been specifically approved for a child's particular disease, then insurance companies typically will not cover it because the treatment is considered 'off-label' or 'experimental.'
Hagan discusses insurance challenges for unapproved treatments for children.
Share & report
More from Kay Hagan
I am one of the biggest proponents of STEM education in the Senate, because it is so important for the jobs today.
Mr. President, I ask unanimous consent that the Committee on Finance be authorized to meet during the session of the Senate on July 10, 2013, at 2:30 p.m., in room SD-215 of the Dirksen Senate Office Building, to conduct a hearing entitled…
Other voices in this conversation
